fludarabine and Diseases, Metabolic

fludarabine has been researched along with Diseases, Metabolic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, N; Bollard, CM; Brenner, MK; Carrum, G; Gottschalk, S; Heslop, HE; Krance, RA; Leung, KS; Myers, GD; Rosenblatt, H	1

Other Studies

1 other study(ies) available for fludarabine and Diseases, Metabolic

Article	Year
Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2008, Volume: 14, Issue:11 Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Living Donors; Lymphocyte Transfusion; Male; Metabolic Diseases; Prospective Studies; Retrospective Studies; Severe Combined Immunodeficiency; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Vidarabine	2008

Article

Year

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2008, Volume: 14, Issue:11

Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Living Donors; Lymphocyte Transfusion; Male; Metabolic Diseases; Prospective Studies; Retrospective Studies; Severe Combined Immunodeficiency; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Vidarabine

2008